Overwhelming feelings of sadness, despair, worthlessness, and loneliness that affect sleep, diet, social relations and daily functioning are common in those with depression.
Transcranial Magnetic Stimulation (TMS) is FDA-approved and covered by most major insurances for Multi-Medication Resistant Major Depressive Disorder in adults.
MeRT is an individualized application of TMS that tailors treatment to meet the exact needs of your brain, alleviating the symptoms and severity of depression.
People with depression typically have asymmetrical or uneven brainwave activity across hemispheres. Specifically, altered Alpha and Theta wave activity are present between the left and right frontal hemispheres. TMS and MeRT help to organize brainwave activity across both hemispheres of the brain with the goal of reducing symptoms of depression for the patient.
Anxiety in moderation is normal. However, significant anxiety is uncomfortable and detrimental to one’s mental, emotional, and physical health. It is estimated that nearly 1 in 5 adults meet clinical standards for some form of anxiety disorder, such as Generalized Anxiety Disorder, Panic Disorder, Social Anxiety Disorder, and Obsessive Compulsive Disorder. TMS and MeRT are alternative, non-pharmaceutical treatments that may help those with high levels of anxiety. TMS is approved by the FDA for treating Obsessive Compulsive Disorder.
Individuals with anxiety disorders generally have higher levels of brain waves that are “too fast” across multiple areas of the brain. MeRT works to calm any overactive brainwave activity by resetting neural connections with gentle magnetic waves.
In a 2008 study, 60% of participants who completed treatment showed reductions of 50% or more on anxiety scales (Bystritsky et al., 2008).
Autism is a complex disorder that affects each person differently. People with autism may exhibit impacted language, social skills, behavior, cognition, and ability to function independently. MeRT is one of the few medical treatment options that can help autism.
Brainwaves of those with autism often show patterns of disorganization in the front 3/4 of the brain. Brainwaves in these areas consist of a mix of slow (Delta & Theta) and fast (Beta) frequency behavior whereas a neurotypical brain would usually have one dominant frequency in the Alpha band range. MeRT entrains the front of the brain to be less disorganized and increase whole brain coherence. Often, this results in improved sleep, social behavior and overall better quality of life for the child & the family.
In an internal double blind controlled trial, 66% of individuals experienced increased communication (verbal & nonverbal) and 70% experienced increased eye contact. Many of our patients also report improvements in social awareness and engagement, emotion regulation, and sensory sensitivities with MeRT (Wave Neuro).
We offer MeRT to treat the early symptoms and behaviors of early-stage dementia and memory loss. Although MeRT is not a cure for dementia, it can help to slow the progression of dementia as well as alleviate co-morbid symptoms such as anxiety, depression, and brain fog.
Brainwave patterns of those with dementia include overall disorganized brain connectivity with unique markers on the qEEG. MeRT trains areas of abnormal brain functioning back to a normal level of brain functioning. Many report that MeRT alleviates mood and cognitive changes related to increasing memory loss.
Post-Traumatic Stress Disorder (PTSD) can occur in anyone at any age in response to highly distressing experience(s). PTSD is linked to physically altered brain functioning, which can affect various areas of a person’s life from their sleep, relationships, and daily functioning.
Those with PTSD often exhibit asymmetrical or uneven brainwave activity between the front and back of the brain. Oftentimes, there are two competing Alpha frequencies in the frontal lobe and excessive Theta & Delta in other areas of the brain. MeRT works to reshape abnormal Theta & Delta brainwave activity caused by trauma to a single, optimal Alpha frequency across the brain. Many with PTSD report improved sleep, cognitive processing, emotional stability, and greater sense of well-being with MeRT.
In a 2015 study, all participants who completed MeRT therapy exhibited some decrease in their PTSD symptoms. On average, participants exhibited a 42% reduction in their PTSD symptoms on PCL-M measures (Taghva et al. 2015).
Persistent and chronic symptoms following recovery from COVID-19 have been termed “Long COVID Syndrome” by medical and research experts. In many cases, the COVID-19 virus infiltrates neural tissues causing brain fog, fatigue, and more.
Brainwave patterns of those with post COVID-19 symptoms include overall disorganized neural connectivity with unique markers on each individual’s qEEG. MeRT recalibrates abnormal brainwaves so that they may function at your brain’s optimal frequency. With improved brainwave functioning, symptoms and severity of Long Covid Syndrome are reduced.
Brain injuries are debilitating. They affect everything from mood, cognition, memory, language, focus, and other functions depending on the impacted area(s) of the brain. MeRT is one of the few non-surgical treatments available that heals impacted brain connections to accelerate recovery from TBI and concussions.
Brainwave patterns in those with TBIs or concussive disorders include asynchronous brainwave activity across the brain with unique markers on each individual’s qEEG. MeRT targets and resets abnormal neural connections to ideal frequencies, which reduces clinical symptoms.
Central sleep apnea occurs when breathing stops and starts repeatedly during sleep due to poor communication between the brain and body. Sleep apnea is often associated with poor sleep, snoring, chronic fatigue, headache, and other symptoms.
Individuals with central sleep apnea linked to brainwave dysfunction may show dysregulation in the brain with excessive fast and slow brainwaves. MeRT helps by optimizing neural connections to improve brain-body communication to improve your sleep.
Many who are addicted to smoking try and fail to quit. Addictions have brain based components, which make it difficult to stop on one’s own. TMS was recently approved by the FDA for treating smoking cessation in adults.
Individuals who smoke often have abnormal brainwave activity in areas of the brain linked to addiction such as the bilateral insula and prefrontal cortex. MeRT can help reduce cravings for smoking by optimizing areas of the brain that contribute to addictive tendencies.
Migraines are a disabling neurological disease with varying symptoms that last anywhere from hours to days. Treating migraines can be challenging. TMS is FDA approved for the treatment of migraines with aura.
People with migraines often show imbalanced brain connections that are connecting “too fast” and “too slow” in unique areas. MeRT helps to optimize communication between neurons so that they operate at your brain’s ideal speed.
For all conditions treated with TMS and MeRT, results vary per individual and are not guaranteed.